8 results were returned
Bird & Bird LLP advised Materia on the acquisition of all shares in German licensed medicinal cannabis distributor Cannaktiv GmbH. The deal provides Materia – an international manufacturer and distributor of medicinal ...
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
We were successful in defending our clients in a major Supplementary Protection Certificate (SPC) case.
Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...
We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes.
We are delighted to announce that our Life Sciences team has won two awards at the 8th annual LMG European Life Sciences Awards 2020.
International law firm Bird & Bird joins 26 organisations in a European Commission funded project that draws on big data to improve the health and wellbeing of European citizens. The four-year project aims to build a ...
International law firm Bird & Bird advises international semiconductor design company, Arm, pro bono on a 15-month project in partnership with Be Healthy Be Mobile (a joint initiative between the World Health ...